Sage Journals: Discover world-class research

Abstract

MicroRNAs (miRNAs) are critically important in both normal neuronal development and neurological diseases. Although cerebral ischemia has been shown to alter the miRNA profiles of rats, the role of miRNA in the cornu ammonis 1 region of the gerbil hippocampus under ischemic tolerance has not been studied. In the present study, Mongolian gerbils were subjected to one or three times the nonlethal dose of 2-min transient common carotid artery occlusion (tCCAO). miRNA microarray technology detected 251 miRNAs and the expression of seven of these in terms of ischemic tolerance. They were compared at different time points: 1 day, 7 days, 1 month, and 6 months. mmu-miR-15a-5p, related to neurogenesis, showed increased expression after one dose of 2-min tCCAO and was much higher after three doses. An increase in sha-miR-24 and oan-let-7b-3p, related to transactivation response DNA-binding protein (TDP43), was observed after one dose of 2-min tCCAO, but the peak was accelerated to an earlier period of reperfusion after three doses. In contrast, mmu-miR-125b-5p and mmu-miR-132–5p, related to fused in sarcoma/translocated in liposarcoma (FUS/TLS), showed similar increases at both doses. mmu-miR-181c-5p and mmu-miR-378a-5p, related to heat shock protein 70 (HSP70), also showed accelerated expression after three doses. This data set provides new insight about miRNA expression during neurogenesis, and related to TDP43, FUS/TLS, and HSP70, which may be useful when pursuing further studies on the possible use of miRNAs as biomarkers in cerebral ischemic tolerance and neuroregeneration.

Keywords

MicroRNA (miRNA)Ischemic preconditioning Cornu ammonis 1 (CA1)Gerbil

Introduction

MicroRNAs (miRNAs) are small noncoding ribonucleic acids (RNAs) that regulate gene expression at the posttranscriptional level (19,45). They function by binding to complementary sites on the 3′ untranslated region of genes and promote the recruitment of protein complexes responsible for degrading messenger RNA (mRNA) and/or impairing translation (31). The human genome has been estimated to contain up to 1,000 miRNAs, and each miRNA affects approximately 200 species of mRNAs (32). However, gerbil miRNAs have not yet been examined.

Several miRNAs have been found to target transcription factors regulating embryonic stem cell (ESC) self-renewal and differentiation (44,50), and other miRNAs have been shown to facilitate critical reprogramming toward induced pluripotent stem cells (iPSCs) (4,22,47). Recent studies showed that various pathological conditions significantly altered cerebral miRNA profiles, which could affect the disease outcome (7) in Alzheimer's disease (AD) (20), stroke (21,34), tumor growth (40), Down syndrome (25), and schizophrenia (6).

We previously reported that a single 2-min ischemia induced no neuronal damage, but three repeated 2-min ischemic insults caused neuronal damage, and significant neuronal cell recovery subsequently occurred in the selectively vulnerable region cornu ammonis 1 (CA1) in the hippocampus (48). Short-period transient ischemia can induce ischemic tolerance (23), which is a protective response against several subsequent lethal ischemias and can induce change in the cerebral miRNAome (13,43). Ischemic preconditioning offers endogenous neuroprotection by changing gene expression and altering protein synthesis (46). miRNAs are critically important to both normal neuronal development and in many neurological diseases. The gerbil model of transient global cerebral ischemia is well studied, particularly the underlying mechanisms of ischemic tolerance mainly to the pyramidal neurons in the hippocampal CA1 region. Increased induction of neuronal apoptosis is known to occur in this model (30). However, the role of miRNA in the CA1 region of the gerbil hippocampus in ischemic tolerance and following neurogenesis has not yet been studied.

We hypothesized that miRNAs may serve as important mediators of RNA processing and resulting protein synthesis required for ischemic tolerance as well as neurogenesis. Thus, we examined changes in miRNA expression in the preconditioned gerbil hippocampal CA1 sector after transient common carotid artery occlusion (tCCAO).

Materials and Methods

Experimental Model

Experiments were performed with male Mongolian gerbils (Japan SLC Inc., Shizuoka, Japan). The 10- to 12-week-old gerbils weighing about 80 g were maintained in a temperature-regulated room (23–25°C) at a 12-h light/dark cycle for at least 7 days. The gerbils were fasted, but were allowed free access to water overnight before surgery. In total, 18 gerbils were randomized into three groups. When the animals began to regain consciousness after anesthesia, both common carotid arteries (CCAs) of the first and second groups (n = 8 each) were occluded with surgical microclips (RS-5424; Roboz Surgical Instrument Co., Gaithersburg, MD, USA) for 2 min of tCCAO. For the second group (n = 8), secondary occlusion of both CCAs for 2 min was induced 2 days later, and then in the same way for tertiary occlusion, with a total of three rounds of tCCAO at 2-day intervals. Gerbils of the sham control (SC) group were treated only once with a neck incision without any artery occlusion. The animals were allowed to recover for 1 day, 7 days, 1 month, or 6 months at ambient temperature (23–25°C), then were deeply anesthetized with pentobarbital (IP, 40 mg/kg; Kyoritsu Seiyaku Corporation, Saitama, Japan) and decapitated. SC animals were sacrificed in the same way just after the sham operation.

tCCAO and Reperfusion

Transient global forebrain ischemia was induced into gerbils by occluding bilateral CCA, as per our previous method (3). Briefly, gerbils were lightly anesthetized after inhaling a nitrous oxide/oxygen/isoflurane (69%:30%:1%; Air Water Inc., Okayama, Japan) mixture. Body temperature was monitored in all animals, and was maintained at 37 ± 0.3°C by using a heating pad (model BMT-100; Bio Research Center, Nagoya, Japan) during surgery. A midline neck incision was made, and both CCAs were exposed. Animals began to regain consciousness after the end of anesthesia, and both CCAs were occluded with surgical microclips. After 2 min of tCCAO, cerebral blood flow was restored by removing the microclips. At 1 day, 7 days, 1 month, and 6 months after reperfusion, the animals were euthanized as described above (n = 2) using a previously defined method (28). Then, all brains were dissected, quickly frozen in powdered dry ice, and stored at −80°C until subsequent preparation.

All animal experiments were approved by the Animal Committee of the Graduate School of Medicine and Dentistry, Okayama University. All institutional and national guidelines for the care and use of laboratory animals were followed.

Total RNA (Including miRNA) Isolation From Gerbil Brain Samples

The bilateral hippocampal CA1 region of the frozen brain was dissected and combined in a cryostat (HM 500M; Microm Inc., Mound, MN, USA) at −18°C. Total RNA containing miRNA was isolated from about 5 μg of the hippocampal CA1 region suspended in RNA-Later ICE (Ambion Inc., Austin, TX, USA) using a mirVana^™ miRNA Isolation Kit (Ambion). The concentration, quality, and integrity of total RNA were determined using a NanoDrop Spectrophotometer (ND-1000; NanoDrop Tech, Rockland, DE, USA). The ratio of OD₂₆₀/OD₂₈₀, which was >1.8 for all RNA samples, was used to ascertain the quality of RNA. RNA samples were stored at −80°C before miRNA array studies.

Gerbil miRNA Sequencing

For each SC or ischemic brain sample, an equal amount of total RNA was pooled from three biological replicates to generate enough RNA (approximately 1,000 ng) for deep sequencing (Table 1). Briefly, the isolated total RNAs of each sample were resolved on a denaturing 15% polyacrylamide gel (Bio-Rad Laboratories, Hercules, CA, USA) for size selection, and these small RNAs (≤30 bases) were ligated to a pair of Solexa adaptors at the 5′ and 3′ ends using T4 RNA ligase. After ligation and purification, adapter-ligated small RNAs were reverse transcribed and amplified for 15 cycles (cDNA RT-PCR) with a pair of adapter complementary primers in order to produce sequencing libraries. PCR products were then purified and directly sequenced using an Illumina HiSeq2000 instrument (Illumina Inc., San Diego, USA).

Table 1.

MicroRNAs Targeted by the Transient Ischemia-Induced MicroRNA

miRNA	Number of Targets	Target Sequence (5′ to 3′)
mmu-miR-15a-5p	337	UAGCAGCACAUAAUGGUUUGUG
sha-miR-24 L+3R+1	1,986	AUCUGGCUCAGUUCAGCAGGAAC
oan-let-7d-3p_R+2	8	CUAUAUAGCCUACUGCCUUCCU
mmu-miR-125b-5p	354	UCCCUGAGACCCUAACUUGUGA
mmu-miR-132–5p	371	AACCGUGGCUUUCGAUUGUUAC
mmu-miR-181c-5p	448	AACAUUCAACCUGUCGGUGAGU
mmu-miR-378a-5p	1,074	CUCCUGACUCCAGGUCCUGUGU

mmu-miRNA, Mus musculus (mouse) microRNA; sha-miR, Sarcophilus harrisii (Tasmanian devil) microRNA; oan-let-7d: Ornithorhynchus anatinus (platypus) let-7d microRNA.

miRNA Microarray Analysis

Groups of gerbils subjected to tCCAO were sacrificed at various reperfusion periods (1 day, 7 days, 1 month, and 6 months; n = 2 at each time point). To perform the miRNA array experiment, total RNA (2–5 μg) was size fractionated on a Microcon centrifugal filter (YM-100; Millipore, Billerica, MA, USA). To the small RNAs (<300 nucleotides), poly-A tails were added at the 3′ end mediated by poly(A) polymerase, and nucleotide tags were ligated to the poly-A tails. Each sample was hybridized to a microarray (LC Sciences, Houston, TX, USA) that contained gerbil miRNA probes. Thereafter, an oligonucleotide was ligated to the poly-A tail for later staining with fluorescent dye Cy3. Hybridization was performed overnight using μParaFlo^® microfluidic technology. Hybridization images were collected using a laser scanner (GenePix 4000B; Molecular Device, Sunnyvale, CA, USA) and digitized using Array-Pro image analysis software (Media Cybernetics, Bethesda, MD, USA). Correlations between fluorescence signal intensities from the laser scanner and expression levels of different miRNA sequences were generally proportional. Since fluorescence intensity was the read-out of the laser scanner, fluorescence intensity data were expressed with no absolute units in the figures of this study.

Statistical Analysis

All data in this study are presented as means ± SD. Data from different groups were normalized and statistically analyzed using one-way ANOVA, followed by Tukey's post hoc comparison. The normalized hybridization data of the microarrays were subjected to hierarchical cluster analysis using the Euclidian distance function. To increase the validity of the data, cross-comparison matrices were generated. For example, data from the two sham chips were crosscompared with the two tCCAO chips (at each time point) to generate a matrix of four comparisons. Statistical analyses were performed using SPSS (ver. 13.0; IBM, Armonk, NY, USA). All tests were considered statistically significant at a value of p < 0.05, as per our previous report (12).

Results

miRNA Expression Profile in Gerbil Hippocampus

A total of 1,067 miRNAs (LC Sciences, Houston, TX; USA) were screened in samples of the CA1 region from gerbils subjected to tCCAO. A total of 251 miRNAs were detected in samples of one or three doses of tCCAO. Since no miRNA data for gerbils are available, the sequences of mouse and some other animal species' miRNAs were used for this study (Fig. 1A, Table 1). Each column in Figure 1B–E represents a single sample, and each row represents a single miRNA. Black squares represent the median level of miRNA, and green or red squares represent lower or higher levels than the median level of miRNA expression, respectively.

Figure 1.

Time-dependent profiles of microRNA expression in gerbil hippocampus. Hierarchical clustering of miRNAs detected in the hippocampal CA1 region showed four distinct clusters for neuroprotection and protein expression. Each column represents a single sample, and each row represents a single miRNA. Black squares represent median level of miRNA, and green or red squares represent lower or higher levels than the median level of miRNA expression, respectively (A). Clusters B, C, D, and E contained miRNAs related to neurogenesis, 43 kDa transactivation response DNA-binding protein (TDP43), fused in sarcoma/translocated in liposarcoma (FUS/TLS), and heat shock protein 70 (HSP70), respectively. tCCAO, transient common carotid artery occlusion; mmu-miR, Mus musculus (mouse) microRNA; oan-let-7b, Ornithorhynchus anatinus (platypus) let-7d microRNA; sha-miR-24, Sarcophilus harrisii (Tasmanian devil) microRNA 24.

Hierarchical clustering of the miRNAs detected in the brain showed four distinct clusters for neurogenesis and protein expression (Fig. 1B–E). Cluster B contained Mus musculus (mouse)-let-7b (mmu-let-7b), Macaca mulatta (rhesus monkey; mml)-miR-9, mmu-miR-10b, mmu-miR-15a, mmu-miR-15b, Equus caballus (horse; eca)-miR-16, mmu-miR-16, mmu-miR-20 (a, b), mmu-miR-28 (a, b), mmu-miR-29 (a, b, c), mmu-miR-34 (a, b, c), mmu-miR-124, mmu-miR-128, oan-miR-128, mmu-miR-125b, Ornithorhynchus anatinus (platypus; oan)-miR-125, mmu-miR-133 (a, b), mmu-miR-146b, Gorilla gorilla gorilla (gorilla; ggo)-miR-146b and rno-miR-146b, related to neurogenesis (18,27,29); cluster C contained mmu-let-7 (b, d, i), oan-let-7b, Canis familiaris (dog; cfa)-mir-24, mmu-miR-24, Sarcophilus harrisii (Tasmanian devil; sha)-miR-24, mmu-miR-33, mmu-miR-132, mmu-miR-143, mmu-miR-330, and mmu-miR-574, related to 43 kDa trans-activation response DNA-binding protein (TDP43) (9,10, 24); cluster D contained mmu-miR-9, oan-miR-9, mmu-miR-12, mmu-miR-132, mmu-miR-192, mmu-miR-199 (a, b), and sha-miR-199a, related to fused in sarcoma/translocated in liposarcoma (FUS/TLS) (38); cluster E contained mmu-miR-181 (c, d), mmu-miR-200 (a, b, c), and mmu-miR-378 (a, b, c, d), related to heat shock protein 70 (HSP70) (41,49).

Target Analysis of Differently Expressed miRNAs

Among the above four clusters, miRNA expression profiles for mmu-miR-15a-5p, sha-miR-24_L+3R+1, oan-let-7b-3p_R+2, mmu-miR-125b-5p, mmu-miR-132–5p, mmu-miR-181c-5p, and mmu-miR-378a-5p were compared in the CA1 subfield of gerbils subjected to one or three doses of 2-min tCCAO. Heat maps showed the pattern of miRNA expression among the different experimental groups. These expressed miRNAs were used for further analyses (Figs. 2, 3, 4).

Figure 2.

mmu-miR-15a-5p expression during neuroprotection. From the signal strength of 820 ± 22 in SC brains (gray circle), the signal strength slowly, but progressively, increased in the CA1 region after 2-min tCCAO for one dose (open diamonds) and three doses (filled squares). Note the higher strength after three doses versus one dose (*p < 0.05 vs. SC, **p < 0.01 vs. SC).

Figure 3.

MicroRNA changes for FUS/TLS and TDP43. MicroRNA changes from baseline SC brains (gray circles) for FUS/TLS (A, C) and TDP43 (B, D). The signal strength of mmu-miR-125b-5p and mmu-miR-132–5p showed a similar increasing pattern in both groups of 2-min tCCAO for one dose (open diamonds) and three doses (filled squares) (*p < 0.05 vs. SC) (A, C). In contrast, the peak time of sha-miR-24 and oan-let-7b-3p accelerated to 1 day from three doses (filled squares) to one dose (open diamonds), then gradually returned until 6 months (*p < 0.05 vs. SC, **p < 0.01 vs. SC) (B, D).

Figure 4.

MicroRNA changes for HSP70. Note the peak time acceleration to 1 day and 7 days from one dose (open diamonds) to three doses (filled squares), with a gradual return to 6 months in mmu-miR-181c-5p and mmu-miR-378a-5p (*p < 0.05 vs. SC, **p < 0.01 vs. SC.

mmu-miR-15a-5p Expression for Neurogenesis

The signal strength of mmu-miR-15a-5p for the hippocampal CA1 region is shown in Figure 2. Signal strength was 820 ± 22 in the SC brains (Fig. 2, circle). After one dose of 2-min tCCAO, the signal strength was slowly, but progressively, induced in the CA1 region. From the baseline of the SC level, the strength of miRNA increased to 943 ± 153, 1,125 ± 196, 1,163 ± 37, and 1,373 ± 244 at 1 day, 7 days, 1 month, and 6 months, respectively (Fig. 2, open diamonds). In the group of three doses of 2-min tCCAO, the signal strength showed a similar pattern to that of the one dose, but the strength was much higher: 1,301 ± 186, 1,438 ± 311, 1,525 ± 356, and 1,386 ± 166 at 1 day, 7 days, 1 month, and 6 months, respectively (*p < 0.05 vs. SC, **p < 0.01 vs. SC, filled squares) (Fig. 2).

sha-miR-24 and oan-let-7b-3p Expression for TDP43

The signal strength of sha-miR-24_L+3R+1 was 7,098 ± 920 in the hippocampal CA1 region of the SC brains (Fig. 3B, circle). From the baseline level of the SC brain, the strength of miRNA increased to 9,327 ± 2,889 and 12,134 ± 240 at 1 day and 7 days, peaked at 1 month (13,790 ± 2,885) then slightly returned at 6 months (11,543 ± 1,776) after one dose of 2-min tCCAO (Fig. 3B, open diamonds). In the group of three doses of 2-min tCCAO, the peak time accelerated to 1 day (13,122 ± 781), then gradually returned until 6 months. The strength of miRNA was 12,421 ± 2,319, 12,452 ± 1,159, 10,586 ± 167 at 7 days, 1 month, and 6 months, respectively (*p < 0.05 vs. SC, **p < 0.01 vs. SC, filled squares) (Fig. 3B).

The signal strength of oan-let-7b-3p_R+2 was 18 ± 2 in the hippocampal CA1 region of the SC brains (Fig. 3D, circle). From the baseline level of the SC brain, the strength of miRNA increased to 17 ± 1, 25 ± 16, 30 ± 18, and 46 ± 11 at 1 day, 7 days, 1 month, and 6 months, respectively, after one dose of 2-min tCCAO (Fig. 3D, open diamonds). In the group of three doses of 2-min tCCAO, the signal strength peaked at 1 day (63 ± 18), then returned from 7 days to 6 months. The strength of miRNA was 46 ± 6, 35 ± 1, and 32 ± 6 at 7 days, 1 month, and 6 months, respectively (*p < 0.05 vs. SC, **p < 0.01 vs. SC, filled squares) (Fig. 3D).

mmu-miR-125b-5p and mmu-miR-132–5p Expression for FUS/TLS

The signal strength of mmu-miR-125b-5p and mmu-miR-132–5p for the hippocampal CA1 region is shown in Figure 3A and 3C. The signal strength of mmu-miR-125b-5p (Fig. 3A) showed a similar increasing pattern in both groups of 2-min tCCAO at both doses. From the baseline level of the SC brain (17,508 ± 2,915) (Fig. 3A, circle), the strength of mmu-miR-125b-5p was 18,392 ± 2,680, 25,851 ± 715, 27,273 ± 166, 22,717 ± 3,889 at 1 day, 7 days, 1 months, and 6 months after one dose of 2-min tCCAO (Fig. 3A, open diamonds), and 24,879 ± 456, 26,344 ± 152, 24,574 ± 1,301, 26,728 ± 1,236 at 1 day, 7 days, 1 months, and 6 months after three doses (*p < 0.05 vs. SC, filled squares) (Fig. 3A).

The signal of mmu-miR-132–5p increased and peaked at 1 day then was downregulated from 7 days to 6 months in both groups (Fig. 3C). From the baseline level of the SC brain (705 ± 30, Fig. 3C, circle), the strength of mmu-miR-132–5p was 769 ± 209, 710 ± 57, 601 ± 37, 541 ± 46 at 1 day, 7 days, 1 month, and 6 months after one dose of 2-min tCCAO (Fig. 3C, open diamonds), and 1,009 ± 152, 637 ± 64, 574 ± 71, 678 ± 176 at 1 day, 7 days, 1 month, and 6 months after three doses (*p < 0.05 vs. SC, filled squares) (Fig. 3C).

mmu-miR-181c-5p and mmu-miR-378a-5p Expression for HSP70

The signal strength of mmu-miR-181c-5p was 530 ± 45 in the hippocampal CA1 region of the SC brains (Fig. 4A, circle). From the baseline level of the SC brain, the signal strength of miRNA increased to 2,056 ± 2,091, 2,587 ± 1,144, and 3,094 ± 144 at 1 day, 7 days, and 1 month, peak at 1 month, then returned slightly at 6 months (2,479 ± 892) after one dose of 2-min tCCAO (Fig. 4A, open diamonds). In the group of three doses of 2-min tCCAO, the peak time accelerated to 1 day (3,330 ± 224), then gradually returned to 3,278 ± 772, 2,675 ± 226, and 1,870 ± 264 at 7 days, 1 month, and 6 months, respectively (*p < 0.05 vs. SC, **p < 0.01 vs. SC, filled squares) (Fig. 4A).

The signal strength of mmu-miR-378a-5p was 56 ± 8 in the hippocampal CA1 region of the SC brains (Fig. 4B, circle). From the baseline of the SC level, the strength of miRNA decreased to 56 ± 2, 48 ± 7, 42 ± 1, and 52 ± 8 at 1 day, 7 days, 1 month, and 6 months, respectively, after one dose of 2-min tCCAO (Fig. 4B, open diamonds). In the group of three doses of 2-min tCCAO, signal strength was induced in the CA1 region with a peak time at 7 days (75 ± 23), then returned from 1 month to 6 months. The strength of miRNA was 58 ± 1, 68 ± 3, and 55 ± 0 at 1 day, 1 month, and 6 months, respectively (*p < 0.05 vs. SC, **p < 0.01 vs. SC, filled squares) (Fig. 4B).

Discussion

In the present study, miRNA microarray technology detected 251 miRNAs from the hippocampal CA1 region of gerbils after tCCAO. Among these miRNAs, seven miRNA expression profiles were compared in terms of ischemic tolerance in gerbils subjected to one or three doses of 2-min tCCAO (Table 1, Fig. 1). mmu-miR-15a-5p for neurogenesis showed increased expression after one dose of 2-min tCCAO, which was much higher in the three-dose group (Fig. 2). Time-dependent increases of sha-miR-24 and oan-let-7b-3p for TDP43 were observed after one dose of 2-min tCCAO, but the peak time accelerated to an earlier period of reperfusion after three doses (Fig. 3B, D). In contrast, mmu-miR-125b-5p and mmu-miR-132–5p for FUS/TLS showed a similar increase in both groups after one or three doses (Fig. 3A, C). mmu-miR-181c-5p and mmu-miR-378a-5p for HSP70 also showed accelerated expression after three doses (Fig. 4).

Mongolian gerbils are particularly susceptible to bilateral carotid occlusion, which results in transient global brain ischemia, due to an incomplete circle of Willis (15). We already reported typical cresyl violet staining of the hippocampal CA1 region in our previous article (48). Moreover, hippocampal CA1 cells are the most vulnerable region in cerebral ischemia (17). CA1 pyramidal neurons both in experimental animals and in humans undergo selective cell death after transient ischemia (8). No change in cell density of the CA1 pyramidal neurons was observed between the SC group and the gerbil group subjected to a single 2-min tCCAO from 1 day to 6 months later. However, in the gerbil group subjected to 2-min tCCAO three times, neuronal loss was observed in the CA1 region. Although most hippocampal CA1 neurons survived at 1 day after 3 × 2-min tCCAO, large numbers of CA1 neurons were gradually lost from 3 to 7 days. After the significant loss at 7 days, CA1 cell density gradually recovered from 1 to 6 months (48). Although single 2-min ischemia depletes high-energy phosphate compounds and perturbs protein synthesis, it has not been reported to cause neuronal death. Therefore, 2-min ischemia was selected as mild ischemic treatment for subsequent neuroprotection (36). In the gerbils' hippocampal CA1 regions, 2-min ischemia for ischemic preconditioning is extremely effective in providing protection against cell death.

Our previous study showed that ischemic preconditioning offers a way to induce endogenous neuroprotection and neurogenesis in gerbils (48). Changes in TDP43, FUS/TLS, and HSP70 proteins were involved in this function. Significant changes to TDP43 and FUS/TLS were observed in the ischemic brains. The colocalization of TDP43 with markers for RNA transport and stress granules suggests that TDP43 may play a role in sequestering and regulating the stability of mRNAs necessary for the neuronal response to stress or injury (37). TDP43 and FUS/TLS are both DNA/RNA-binding proteins involved in transcriptional regulation, mRNA splicing, transport, and translation (39). Previously, we showed that ischemic preconditioning accelerated HSP70 gene expression at the transcriptional level, ameliorated the translational disturbance of mRNA to protein, and saved CA1 cells from subsequent lethal ischemia (2). Molecular mechanisms indicate how ischemic preconditioning alters the balance between cell survival and cell detrimental signaling pathways.

Transient cerebral ischemia reprograms the response of nerve cells for subsequent ischemia. A previous report suggested that neuroprotection by a short period of transient ischemia may depend on altered miRNA expression (46). Ischemic tolerance can be obtained by a large change in gene expression, the functions of which influence protein turnover, cell cycle regulation, and ion channel abundance. For this tolerance, an endogenous genomic program may be present, serving as an adaptation to improve survival against oxygen limitation (14). The microarray findings in this study suggest that miRNAs are effectors of ischemic tolerance (Fig. 1).

The present study shows that transient forebrain ischemia induces a gradual increase of miR-15a neurogenesis in the hippocampus (Fig. 2). We previously found that three repetitions of 2-min ischemia caused neuronal damage in selectively vulnerable hippocampal CA1 neurons, but exhibited a significant recovery after 7 days to 6 months (48). In the present study, miR-15a showed an increase up to 6 months after one dose of 2-min tCCAO, but the increase was much greater in the three-dose group (Fig. 2, filled squares). As was reported in cancer cells (11,35), miRNA-15 may promote neuronal survival by regulating neurogenesis and the apoptosis pathway in this tCCAO model.

Related to the miRNA pathway, TDP43 and FUS/TLS are associated with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (33,38). Let-7b miRNA expression was downregulated following TDP43 knockdown in culture cells (10), and the expression of some miRNAs decreased or increased in TDP43 mutant flies (18). miR-24–1* was lower in a PGRN [+, (pro) granulin] FTLD TDP patient than in a PGRN (–) FTLD TDP patient (24). FUS affects the biogenesis of miRNAs for neuronal function, differentiation, and synaptogenesis with miR-125b and miR-132 (16,26,42). The present study showed that the expression of miR-24 and let-7b for TDP43 accelerated to an earlier period of reperfusion after three doses (Fig. 3B, D), but the expression of mmu-miR-125b-5p and mmu-miR-132–5p for FUS/TLS did not show any evident acceleration (Fig. 3A, C). We previously found that the redistribution of both TDP43 and FUS/TLS immunoreactivity to cytoplasm was accelerated to an earlier period of reperfusion after three doses of 2-min tCCAO from 3 months to 7 days or from 7 days to 1 day, respectively (48). Thus, the remarkable acceleration of TDP43 may be well correlated to the present expression data of miR-24 and let-7b for TDP43 (Fig. 3B, D).

HSP70 is a major stress protein, which is strongly induced under stresses including cerebral ischemia, heat, and metal toxicity (1,3,5). miR-181 was identified as a regulator of several HSP70 family members, and an increased level of miR-181a is associated with a decrease in endoplasmic reticulum GRP78 protein related to cerebral ischemic injury (41). Cardiac ischemic preconditioning of mice decreased HSP70 related to miR-378* microRNAs (49). Our previous immunohistochemical finding that HSP70 was induced only at 7 days after three doses of 2-min tCCAO is well correlated to our present data of mmu-miR-181c-5p and mmu-miR-378–5p, which accelerated at 1–7 days (48) (Fig. 4).

In summary, the present study shows the profiling of miRNAs for ischemic preconditioning after tCCAO in gerbil and identifies distinct regulation patterns for seven miRNA clusters. These data could provide new perspectives of miRNA expression proteins for neuroprotection, TDP43, FUS/TLS, and HSP70, not only in transient cerebral ischemia but also in ischemic preconditioning. These results may be useful for pursuing further studies on the possible use of miRNAs as biomarkers in cerebral ischemia and neuroregeneration.

Footnotes

Acknowledgments

This work was partly supported by a Grant-in-Aid for Scientific Research (B) 21390267, (C) 24591263, and Challenging Research 24659651, and Grants-in-Aid from the Research Committees (Mizusawa H, Nakano I, Nishizawa M, Sasaki H, and Aoki M) from the Ministry of Health, Labour and Welfare of Japan. The authors declare no conflicts of interest.

References

Abe

Aoki

Kawagoe

Yoshida

Hattori

Kogure

Itoyama

Ischemic delayed neuronal death.

A mitochondrial hypothesis. Stroke 26: 1478–1489; 1995.

Abe

Kawagoe

Aoki

Kogure

Changes of mitochondrial DNA and heat shock protein gene expressions in gerbil hippocampus after transient forebrain ischemia.

J. Cereb. Blood Flow Metab. 13: 773–780; 1993.

Abe

Tanzi

R. E.

Kogure

Induction of HSP70 mRNA after transient ischemia in gerbil brain.

Neurosci. Lett. 125: 166–168; 1991.

Anokye-Danso

Trivedi

C. M.

Juhr

Gupta

Cui

Tian

Zhang

Yang

Gruber

P. J.

Epstein

J. A.

Morrisey

E. E.

Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Cell Stem Cell 8: 376–388; 2011.

Aoki

Abe

Kawagoe

Nakamura

Kogure

Acceleration of HSP70 and HSC70 heat shock gene expression following transient ischemia in the preconditioned gerbil hippocampus.

J. Cereb. Blood Flow Metab. 13(5): 781–788; 1993.

Beveridge

N. J.

Tooney

P. A.

Carroll

A. P.

Gardiner

Bowden

Scott

R. J.

Tran

Dedova

Cairns

M. J.

Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.

Hum. Mol. Genet. 17: 1156–1168; 2008.

Bhalala

O. G.

Srikanth

Kessler

J. A.

The emerging roles of microRNAs in CNS injuries.

Nat. Rev. Neurol. 9: 328–339; 2013.

Bonnekoh

Barbier

Oschlies

Hossmann

K. A.

Selective vulnerability in the gerbil hippocampus: Morphological changes after 5-min ischemia and long survival times.

Acta Neuropathol. 80(1): 18–25; 1990.

Buratti

Baralle

F. E.

The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation.

RNA Biol. 7: 420–429; 2010.

10.

Buratti

De Conti

Stuani

Romano

Baralle

Nuclear factor TDP-43 can affect selected microRNA levels.

FEBS J. 277: 2268–2281; 2010.

11.

Cimmino

Calin

G. A.

Fabbri

Iorio

M. V.

Ferracin

Shimizu

Wojcik

S. E.

Aqeilan

R. I.

Zupo

Dono

Rassenti

Alder

Volinia

Liu

C. G.

Kipps

T. J.

Negrini

Croce

C. M.

miR-15 and miR-16 induce apoptosis by targeting BCL2.

Proc. Natl. Acad. Sci. USA 102: 13944–13949; 2005.

12.

Deguchi

Tsuru

Hayashi

Takaishi

Nagahara

Nagotani

Sehara

Jin

Zhang

Hayakawa

Shoji

Miyazaki

Osaka

Huh

N. H.

Abe

Implantation of a new porous gelatin-siloxane hybrid into a brain lesion as a potential scaffold for tissue regeneration.

J. Cereb. Blood Flow Metab. 26: 1263–1273; 2006.

13.

Dirnagl

Becker

Meisel

Preconditioning and tolerance against cerebral ischaemia: From experimental strategies to clinical use.

Lancet Neurol. 8: 398–412; 2009.

14.

Dirnagl

Simon

R. P.

Hallenbeck

J. M.

Ischemic tolerance and endogenous neuroprotection.

Trends Neurosci. 26: 248–254; 2003.

15.

X. Y.

Zhu

X. D.

Dong

Wang

Zeng

Zhao

T. Y.

H. H.

R. S.

Bai

J. Y.

Chen

Z. W.

Characteristics of circle of Willis variations in the Mongolian gerbil and a newly established ischemia-prone gerbil group.

ILAR J. 52(1): E1–E7; 2011.

16.

Edbauer

Neilson

J. R.

Foster

K. A.

Wang

C. F.

Seeburg

D. P.

Batterton

M. N.

Tada

Dolan

B. M.

Sharp

P. A.

Sheng

Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132.

Neuron 65: 373–384; 2010.

17.

Franklin

T. B.

Krueger-Naug

A. M.

Clarke

D. B.

Arrigo

A. P.

Currie

R. W.

The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system.

Int. J. Hyperthermia 21: 379–392; 2005.

18.

Gascon

Gao

F. B.

Cause or effect: Misregulation of microRNA pathways in neurodegeneration.

Front. Neurosci. 6: 48; 2012.

19.

Ghildiyal

Zamore

P. D.

Small silencing RNAs: An expanding universe.

Nat. Rev. Genet. 10: 94–108; 2009.

20.

Hébert

S. S.

Horré

Nicolaï

Bergmans

Papadopoulou

A. S.

Delacourte

De Strooper

MicroRNA regulation of Alzheimer's amyloid precursor protein expression.

Neurobiol. Dis. 33(3): 422–428; 2009.

21.

Jeyaseelan

Lim

K. Y.

Armugam

MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion.

Stroke 39: 959–966; 2008.

22.

Judson

R. L.

Babiarz

J. E.

Venere

Blelloch

Embryonic stem cell-specific microRNAs promote induced pluripotency.

Nat. Biotechnol. 27: 459–461; 2009.

23.

Kirino

Tsujita

Tamura

Induced tolerance to ischemia in gerbil hippocampal neurons.

J. Cereb. Blood Flow Metab. 11: 299–307; 1991.

24.

Kocerha

Kouri

Baker

Finch

DeJesus-Hernandez

Gonzalez

Chidamparam

Josephs

K. A.

Boeve

B. F.

Graff-Radford

N. R.

Crook

Dickson

D. W.

Rademakers

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations.

BMC Genomics 12: 527; 2011.

25.

Kuhn

D. E.

Nuovo

G. J.

Martin

M. M.

Malana

G. E.

Pleister

A. P.

Jiang

Schmittgen

T. D.

Terry

A. V.

Gardiner

Jr. Head

Feldman

D. S.

Elton

T. S.

Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts.

Biochem. Biophys. Res. Commun. 370: 473–477; 2008.

26.

Laneve

Di Marcotullio

Gioia

Fiori

M. E.

Ferretti

Gulino

Bozzoni

Caffarelli

The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells.

Proc. Natl. Acad. Sci. USA 104: 7957–7962; 2007.

27.

Lee

S. T.

Chu

Jung

K. H.

Kim

J. H.

Huh

J. Y.

Yoon

Park

D. K.

Lim

J. Y.

Kim

J. M.

Jeon

Ryu

Lee

S. K.

Kim

Roh

J. K.

miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model.

Ann. Neurol. 72: 269–277; 2012.

28.

Lee

S. T.

Chu

Jung

K. H.

Yoon

H. J.

Jeon

Kang

K. M.

Park

K. H.

Bae

E. K.

Kim

Lee

S. K.

Roh

J. K.

MicroRNAs induced during ischemic preconditioning.

Stroke 41(8): 1646–1651; 2010.

29.

Lehmann

S. M.

Krüger

Park

Derkow

Rosenberger

Baumgart

Trimbuch

Eom

Hinz

Kaul

Habbel

Kälin

Franzoni

Rybak

Nguyen

Veh

Ninnemann

Peters

Nitsch

Heppner

F. L.

Golenbock

Schott

Ploegh

H. L.

Wulczyn

F. G.

Lehnardt

An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration.

Nat. Neurosci. 15: 827–835; 2012.

30.

Lehotský

Burda

Danielisová

Gottlieb

Kaplán

Saniová

Ischemic tolerance: The mechanisms of neuroprotective strategy.

Anat. Rec. 292(12): 2002–2012; 2009.

31.

Lewis

B. P.

Burge

C. B.

Bartel

D. P.

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Cell 120: 15–20; 2005.

32.

Lewis

B. P.

Shih

I. H.

Jones-Rhoades

M. W.

Bartel

D. P.

Burge

C. B.

Prediction of mammalian microRNA targets.

Cell 115: 787–798; 2003.

33.

Ling

S. C.

Albuquerque

C. P.

Han

J. S.

Lagier-Tourenne

Tokunaga

Zhou

Cleveland

D. W.

ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS.

Proc. Natl. Acad. Sci. USA 107: 13318–13323; 2010.

34.

Liu

D. Z.

Tian

Ander

B. P.

Stamova

B. S.

Turner

R. J.

Jickling

Sharp

F. R.

Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures.

J. Cereb. Blood Flow Metab. 30(1): 92–101; 2010.

35.

Lungu

Kuang

Stoica

Wong

P. K.

Monosodium luminol upregulates the expression of Bcl-2 and VEGF in retrovirus-infected mice through downregulation of corresponding miRNAs.

Acta Virol. 54: 27–32; 2010.

36.

Maysami

Lan

J. Q.

Minami

Simon

R. P.

Proliferating progenitor cells: A required cellular element for induction of ischemic tolerance in the brain.

J. Cereb. Blood Flow Metab. 28: 1104–1113; 2008.

37.

Moisse

Volkening

Leystra-Lantz

Welch

Hill

Strong

M. J.

Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury.

Brain Res. 1249: 202–211; 2009.

38.

Morlando

Dini Modigliani

Torrelli

Rosa

Di Carlo

Caffarelli

Bozzoni

FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment.

EMBO J. 31: 4502–4510; 2012.

39.

Neumann

Rademakers

Roeber

Baker

Kretzschmar

H. A.

Mackenzie

I. R.

A new subtype of frontotemporal lobar degeneration with FUS pathology.

Brain 132: 2922–2931; 2009.

40.

Nicoloso

M. S.

Calin

G. A.

MicroRNA involvement in brain tumors: From bench to bedside.

Brain Pathol. 18: 122–129; 2008.

41.

Ouyang

Y. B.

Yue

L. J.

Xiong

X. X.

White

R. E.

Sun

Giffard

R. G.

miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo.

Neurobiol. Dis. 45: 555–563; 2012.

42.

Pathania

Torres-Reveron

Yan

Kimura

Lin

T. V.

Gordon

Teng

Z. Q.

Zhao

Fulga

T. A.

Van Vactor

Bordey

miR-132 enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons.

PLoS One 7: e38174; 2012.

43.

Saugstad

J. A.

MicroRNAs as effectors of brain function.

Stroke 44: S17–S19; 2013.

44.

Singh

S. K.

Kagalwala

M. N.

Parker-Thornburg

Adams

Majumder

REST maintains self-renewal and pluripotency of embryonic stem cells.

Nature 453: 223–227; 2008.

45.

Small

E. M.

Olson

E. N.

Pervasive roles of microRNAs in cardiovascular biology.

Nature 469: 336–342; 2011.

46.

Stenzel-Poore

M. P.

Stevens

S. L.

Xiong

Lessov

N. S.

Harrington

C. A.

Mori

Meller

Rosenzweig

H. L.

Tobar

Shaw

T. E.

Chu

Simon

R. P.

Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: Similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states.

Lancet 362: 1028–1037; 2003.

47.

Subramanyam

Lamouille

Judson

R. L.

Liu

J. Y.

Bucay

Derynck

Blelloch

Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells.

Nat. Biotechnol. 29: 443–448; 2011.

48.

Sun

Yamashita

Shang

Liu

Deguchi

Liu

Ikeda

Feng

Abe

Acceleration of TDP43 and FUS/TLS protein expressions in the preconditioned hippocampus following repeated transient ischemia.

J. Neurosci. Res. 92(1): 54–63; 2014.

49.

Tranter

Helsley

R. N.

Paulding

W. R.

McGuinness

Brokamp

Haar

Liu

Ren

Jones

W. K.

Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation.

J. Biol. Chem. 286: 29828–29837; 2011.

50.

Papagiannakopoulos

Pan

Thomson

J. A.

Kosik

K. S.

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.

Cell 137: 647–658; 2009.

Time-Dependent Profiles of MicroRNA Expression Induced by Ischemic Preconditioning in the Gerbil Hippocampus

Abstract

Keywords

Introduction

Materials and Methods

Experimental Model

tCCAO and Reperfusion

Total RNA (Including miRNA) Isolation From Gerbil Brain Samples

Gerbil miRNA Sequencing

miRNA Microarray Analysis

Statistical Analysis

Results

miRNA Expression Profile in Gerbil Hippocampus

Target Analysis of Differently Expressed miRNAs

mmu-miR-15a-5p Expression for Neurogenesis

sha-miR-24 and oan-let-7b-3p Expression for TDP43

mmu-miR-125b-5p and mmu-miR-132–5p Expression for FUS/TLS

mmu-miR-181c-5p and mmu-miR-378a-5p Expression for HSP70

Discussion

Footnotes

Acknowledgments

References